Mechanistic Studies in a Phase II Trial of Multiple Sclerosis with Altered Peptide Ligand (APL)
Principal Investigator
Jack Antel | Montreal Neurological Institute | Montreal, QC
Locations
Stony Brook University Hospital | Stony Brook,NY
Washington University at St. Louis | St. Louis,MO
University of New Mexico | Albuquerque,NM
The Ottawa Hospital | Ottawa,Ontario
University of Calgary | Calgary,Alberta
University of British Columbia | Vancouver,British Columbia
Yale University | New Haven,CT
Barrow Neurological Institute | Phoenix,AZ
Texas Neurology | Dallas,TX
University of California, Davis | Sacramento,CA
Montreal Neurological Institute | Montreal,Quebec
Study Code
ITN505AI
Study Status
Complete
